How Transcription, Captioning, Linguistic Validation Can Fuel Growth for LSPs
At SlatorCon Remote December 2022, Michael Rosman and Elizabeth McCullough discuss service delivery opportunities, risks, and barriers to entry.
At SlatorCon Remote December 2022, Michael Rosman and Elizabeth McCullough discuss service delivery opportunities, risks, and barriers to entry.
25-page Slator Pro Guide: Finding Growth in Adjacent Services for LSPs helps identify new opportunities for growth. Includes analysis of barriers to entry, synergies, and risks.
Drug manufacturers want EU regulators to pick one language to go on Covid-19 vaccine labels and instructions for all 27 Member States; EU consumer group says not so fast.
The life sciences sector is one of the major buyers of translation services. Here are 12 commonly translated content types, from clinical trials to product marketing and monitoring.
The world’s most valuable listed language service provider RWS posts small decline in revenues in H1 FY 2020 and updates investors on impact of coronavirus pandemic.
With hundreds of coronavirus clinical studies underway, what role does the language industry play in facilitating the search for a vaccine? Where does linguistic validation fit in?
Europe’s new medical device regulation requires that labeling, packaging, and other content be translated into the official language of each EU country where the device will be sold.
RWS delivers a solid set of numbers as organic growth continues, Moravia delivers record revenues, and British pound weakens.
Slator’s 2019 report on the clinical life sciences translation industry, analysis of the competitive landscape and actionable insights from major buyers of pharmaceutical translation.
Over 100 participants gathered at the Bulgari Hotel in Central London to discuss what’s driving the language industry from AI and automation to emerging buyers and much more.
The combination of ICON’s and Mapi’s language services groups will create a potent rival to language service providers when competing for business with big pharma.
Your information will never be shared with third parties. No Spam.